<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1202</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2019-19-2-39-46</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">FLUORESCENT MODIFICATION OF THE MONOCLONAL ANTIBODIES OLIGOSACCHARIDES BY FLUORESCEIN-5-THIOSEMICARBAZIDE</article-title><trans-title-group xml:lang="ru"><trans-title>СОЗДАНИЕ ФЛУОРЕСЦЕНТНЫХ ЗОНДОВ МЕТОДОМ МОДИФИКАЦИИ ОЛИГОСАХАРИДОВ МОНОКЛОНАЛЬНЫХ АНТИТЕЛ ФЛУОРЕСЦЕИН-5-ТИОСЕМИКАРБАЗИДОМ</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4570-2124</contrib-id><name-alternatives><name xml:lang="en"><surname>Grinevich</surname><given-names>A. S.</given-names></name><name xml:lang="ru"><surname>Гриневич</surname><given-names>А. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>Анатолий Станиславович Гриневич</p><p>115478 Москва, Каширское шоссе, 24</p></bio><email>agrinevich@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5749-5652</contrib-id><name-alternatives><name xml:lang="en"><surname>Chinareva</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Чинарева</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8897-0172</contrib-id><name-alternatives><name xml:lang="en"><surname>Burova</surname><given-names>O. S.</given-names></name><name xml:lang="ru"><surname>Бурова</surname><given-names>О. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1403-8520</contrib-id><name-alternatives><name xml:lang="en"><surname>Ivanov</surname><given-names>P. K.</given-names></name><name xml:lang="ru"><surname>Иванов</surname><given-names>П. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>24 Kashirskoe Shosse, Moscow 115478</p></bio><bio xml:lang="ru"><p>115478 Москва, Каширское шоссе, 24</p></bio><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-06-18" publication-format="electronic"><day>18</day><month>06</month><year>2020</year></pub-date><volume>19</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>39</fpage><lpage>46</lpage><history><date date-type="received" iso-8601-date="2020-06-18"><day>18</day><month>06</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-06-18"><day>18</day><month>06</month><year>2020</year></date></history><permissions><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/1202">https://bioterapevt.abvpress.ru/jour/article/view/1202</self-uri><abstract xml:lang="en"><p><bold><italic>Introduction </italic></bold><italic>Monoclonal antibodies (Mabs) are a good tool for diagnosing human pathologies. They are used as conjugates with fluorescent and other dyes. The classical approach of creating such conjugates is reduced to chemical reactions using the protein base of the Mab.</italic><italic> </italic><italic>At the same time, for a number of Mabs, conjugate production is accompanied by embedding the label into the antigen binding site, which</italic><italic> </italic><italic>leads to a decrease or complete loss of the specific activity of the conjugate. To get out of this situation, the synthesis of fluorescent conjugates by methods of carbohydrate chemistry through spatially distant from the active center oligosaccharides of antibodies is proposed. </italic><bold><italic>Objective </italic></bold><italic>To obtain high activity ICO series Mab conjugates based on the reaction of covalent inclusion of the fluorescent label in the oligosaccharide sequence of the Mab. </italic><bold><italic>Materials and methods </italic></bold><italic>We used Mab series ICO of high purity. Oligosaccharides Mabs oxidized to aldehyde groups, were subjected</italic><italic> </italic><italic>to interaction with fluoriscine-5-thiosemicarboside, followed by the reduction of hydrazone derivative borgidrides. The resulting covalent</italic><italic> </italic><italic>conjugate was investigated in a flow cytometry. </italic><bold><italic>Results </italic></bold><italic>The synthesis of a fluorescent conjugate using monoclonal antibodies oligosaccharides was worked out. Modified monoclonal antibodies retain specific binding to target cells inherent in the native antibody. The resulting conjugates remained active for a long time during storage.</italic><italic> </italic><italic> </italic><bold><italic>Conclusion </italic></bold><italic>An alternative method for conjugation of immunofluorescent, allowing to obtain conjugates of high activity, has been developed.</italic></p></abstract><trans-abstract xml:lang="ru"><p><bold><italic>Введение </italic></bold><italic>Моноклональные антитела (МКАТ) – надежный инструмент диагностики различных заболеваний человека. В этом</italic><italic> </italic><italic>качестве их используют в виде конъюгатов с флуоресцентными и иными метками. Классический подход создания таких</italic><italic> </italic><italic>конъюгатов сводится к химическим реакциям, использующим белковую основу МКАТ. Вместе с тем для целого ряда МКАТ</italic><italic> </italic><italic>синтез конъюгата сопровождается встраиванием метки в антигенсвязывающий участок, что приводит к уменьшению</italic><italic> </italic><italic>или полной потере специфической активности конъюгата. Для выхода из данной ситуации предлагается синтез флуоресцентных конъюгатов методами углеводной химии через пространственно удаленные от активного центра олигосахариды</italic><italic> </italic><italic>антител. </italic><bold><italic>Цель исследования </italic></bold><italic>– получение активных и стабильных при хранении конъюгатов антител серии ICO на основе реакции</italic><italic> </italic><italic>ковалентного включения флуоресцентной метки в олигосахаридную последовательность МКАТ. </italic><bold><italic>Материалы и методы </italic></bold><italic>В исследовании были использованы МКАТ серии ICO высокой степени очистки. Олигосахариды МКАТ</italic><italic> </italic><italic>окисляли до альдегидных групп, подвергали взаимодействию с флуоресцеин-5-тиосемикарбазидом с последующим восстановлением гидразонового производного боргидридами. Полученный ковалентный конъюгат исследовали в прямой реакции иммунофлуоресценции. </italic><bold><italic>Результаты </italic></bold><italic>Отработаны тонкие детали синтеза флуоресцентного конъюгата МКАТ с использованием олигосахаридов</italic><italic> </italic><italic>последнего. Модифицированные МКАТ сохраняли специфическое связывание с клетками-мишенями, присущее нативным</italic><italic> </italic><italic>антителам. Полученные конъюгаты сохраняли свою активность на протяжении длительного времени в процессе хранения. </italic><bold><italic>Заключение </italic></bold><italic>Разработан альтернативный метод для конъюгирования флуоресцентных меток с МКАТ, позволяющий получать</italic><italic> </italic><italic>конъюгаты высокой активности.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>monoclonal antibodies</kwd><kwd>fluorescent conjugates</kwd><kwd>IgG oligosaccharide</kwd><kwd>flow cytometry</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>моноклональные антитела</kwd><kwd>флуоресцентные конъюгаты</kwd><kwd>олигосахарид IgG</kwd><kwd>проточная цитометрия</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Grossberg L., Pressman D. Modification of arginine in the active sites of antibodies. Biochemistry 1968;7(1):272–9. DOI: 10.1021/bi00841a033.</mixed-citation><mixed-citation xml:lang="ru">Grossberg L., Pressman D. Modification of arginine in the active sites of antibodies. Biochemistry 1968;7(1):272–9. DOI: 10.1021/bi00841a033.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Tawfik D.S., Chap R., Eshhar Z., Green BS. pH on–off switching of antibody-hapten binding by site-specific chemical modification of tyrosine. Protein Eng 1994;7(3):431–4. DOI: 10.1093/protein/7.3.431.</mixed-citation><mixed-citation xml:lang="ru">Tawfik D.S., Chap R., Eshhar Z., Green BS. pH on–off switching of antibody-hapten binding by site-specific chemical modification of tyrosine. Protein Eng 1994;7(3):431–4. DOI: 10.1093/protein/7.3.431.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Dwek R.A., Lellouch A.C., Wormald M.R. Glycobiology: “the function of sugar in the IgG molecule”. J Anat 1995;187(Pt 2):279–92.</mixed-citation><mixed-citation xml:lang="ru">Dwek R.A., Lellouch A.C., Wormald M.R. Glycobiology: “the function of sugar in the IgG molecule”. J Anat 1995;187(Pt 2):279–92.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Matsumiya S., Yamaguchi Y., Saito J. et al. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol 2007;4;368(3):767–79. DOI: 10.1016/j.jmb.2007.02.034.</mixed-citation><mixed-citation xml:lang="ru">Matsumiya S., Yamaguchi Y., Saito J. et al. Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1. J Mol Biol 2007;4;368(3):767–79. DOI: 10.1016/j.jmb.2007.02.034.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Lund J., Takahashi N., Popplewell A. et al. Expression and characterization of truncated forms of humanized L243 IgG1. Architectural features can influence synthesis of its oligosaccharide chains and affect superoxide production triggered through human Fcgamma receptor I. Eur J Biochem 2000;267(24):7246–57. DOI: 10.1046/j.1432-1327.2000.01839.x.</mixed-citation><mixed-citation xml:lang="ru">Lund J., Takahashi N., Popplewell A. et al. Expression and characterization of truncated forms of humanized L243 IgG1. Architectural features can influence synthesis of its oligosaccharide chains and affect superoxide production triggered through human Fcgamma receptor I. Eur J Biochem 2000;267(24):7246–57. DOI: 10.1046/j.1432-1327.2000.01839.x.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Гриневич А.С., Краева М.Н., Бурова О.С. и др. Использование олигосахаридов иммуноглобулинов для модификации моноклональных антител. Российский биотерапевтический журнал 2016;15(4):44–8. DOI: 10.17650/1726-9784-2016-15-4- 44-48. [Grinevich A.S., Kraeva M.N., Burova O.S. et al. The use of oligosaccharides of immunoglobulin for modification of monoclonal antibodies. Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy 2016;15(4):44–8. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Гриневич А.С., Краева М.Н., Бурова О.С. и др. Использование олигосахаридов иммуноглобулинов для модификации моноклональных антител. Российский биотерапевтический журнал 2016;15(4):44–8. DOI: 10.17650/1726-9784-2016-15-4- 44-48. [Grinevich A.S., Kraeva M.N., Burova O.S. et al. The use of oligosaccharides of immunoglobulin for modification of monoclonal antibodies. Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy 2016;15(4):44–8. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Ey P.L., Prowse S.J., Jenkin C.R. Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 1978;15(7):429–36. DOI: 10.1016/0161-5890(78)90070-6.</mixed-citation><mixed-citation xml:lang="ru">Ey P.L., Prowse S.J., Jenkin C.R. Isolation of pure IgG1, IgG2a, and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 1978;15(7):429–36. DOI: 10.1016/0161-5890(78)90070-6.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;15;227(5259):680–5. DOI: 10.1038/227680a0.</mixed-citation><mixed-citation xml:lang="ru">Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;15;227(5259):680–5. DOI: 10.1038/227680a0.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Hermanson G.T. Fluorescent Probes. In: Bioconjugate Techniques. 3th Ed. Academic Press, 2013:395–463. DOI: 10.1016/B978-0-12-382239-0.00010-8.</mixed-citation><mixed-citation xml:lang="ru">Hermanson G.T. Fluorescent Probes. In: Bioconjugate Techniques. 3th Ed. Academic Press, 2013:395–463. DOI: 10.1016/B978-0-12-382239-0.00010-8.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Голубцова Н.В., Бурова О.С., Барышников К.А. и др. Моноклональные антитела ICO-406 против антигена CD117. Российский биотерапевтический журнал 2015;14(2):99–104. [Golubtsova N.V., Burova O.S., Baryshnikov K.A. at al. Monoclonal antibodies ICO-406 against the antigen CD117. Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy 2015;14(2):99–104. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Голубцова Н.В., Бурова О.С., Барышников К.А. и др. Моноклональные антитела ICO-406 против антигена CD117. Российский биотерапевтический журнал 2015;14(2):99–104. [Golubtsova N.V., Burova O.S., Baryshnikov K.A. at al. Monoclonal antibodies ICO-406 against the antigen CD117. Rossiyskiy bioterapevticheskiy zhurnal = Russian Journal of Biotherapy 2015;14(2):99–104. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Wolfe C.A., Hage D.S. Studies on the rate and control of antibody oxidation by periodate. Anal Biochem 1995;231(1):123–30. DOI: 10.1006/abio.1995.1511.</mixed-citation><mixed-citation xml:lang="ru">Wolfe C.A., Hage D.S. Studies on the rate and control of antibody oxidation by periodate. Anal Biochem 1995;231(1):123–30. DOI: 10.1006/abio.1995.1511.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Al-Mawali A., Pinto A.D., Busaidi. R.A., Al-Zakwani I. Lymphocyte subsets: reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry 2013;83(8):739–44. DOI: 10.1002/cyto.a.22322.</mixed-citation><mixed-citation xml:lang="ru">Al-Mawali A., Pinto A.D., Busaidi. R.A., Al-Zakwani I. Lymphocyte subsets: reference ranges in an age- and gender-balanced population of Omani healthy adults. Cytometry 2013;83(8):739–44. DOI: 10.1002/cyto.a.22322.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13. Vira S., Mekhedov E., Humphrey G. et al. Fluorescent-labeled antibodies: Balancing functionality and degree of labeling. Anal Biochem 2010;402(2):146–50. DOI: 10.1016/j.ab.2010.03.036.</mixed-citation><mixed-citation xml:lang="ru">Vira S., Mekhedov E., Humphrey G. et al. Fluorescent-labeled antibodies: Balancing functionality and degree of labeling. Anal Biochem 2010;402(2):146–50. DOI: 10.1016/j.ab.2010.03.036.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
